Northborne Partners

Northborne Partners is pleased to announce the release of its 2023 Precision Medical Manufacturing Review and 2024 Outlook. This detailed report provides insight into the following areas of medical contract manufacturing:

• Key learnings from 2023
• Historical sector M&A activity and valuations
• Value drivers that influence company-specific transaction multiples
• Industry landscape and active acquirors

Northborne Partners continues to be extremely active in medical device manufacturing and medtech, more broadly. We have compiled our 2024 outlook based on real-time experience representing multiple clients in the space and conversations with leading industry participants and executives.

Please see the following link to download Northborne’s Precision Medical Manufacturing 2023 Review and 2024 Outlook: Medical Manufacturing 2023 Review 2024 Outlook

For a copy of the full report, please contact one of the Northborne medical manufacturing services team members below.

Ken Higgins
khiggins@northborne.com
612.351.8703

Mike Hirschberg
mhirschberg@northborne.com
612.351.8706

Matt Hansen
mhansen@northborne.com
612.351.8713